(Q45056884)

9 December 2017

Polymorphism of the 4-hydroxylation of debrisoquine in the San Bushmen of southern Africa (English)

1 reference

9 December 2017

0 references

Sommers DK

1

1 reference

PubMed ID

3391625

9 December 2017

Moncrieff J

series ordinal

2

1 reference

PubMed ID

3391625

9 December 2017

Avenant J

series ordinal

3

1 reference

9 December 2017

1 May 1988

1 reference

9 December 2017

1 reference

9 December 2017

7

1 reference

9 December 2017

3

1 reference

9 December 2017

273-276

1 reference

Polymorphic hydroxylation of Debrisoquine in man.

9 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

Genetically determined oxidation capacity and the disposition of debrisoquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

A study of the debrisoquine hydroxylation polymorphism in a Nigerian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

Metoprolol and debrisoquin metabolism in Nigerians: lack of evidence for polymorphic oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F096032718800700308

10.1177/096032718800700308

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference

PubMed ID

3391625